(Q44993694)

8 December 2017

Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis (English)

1 reference

8 December 2017

7

1 reference

8 December 2017

Russo A

1

1 reference

8 December 2017

Stevens JE

2

1 reference

8 December 2017

Giles N

3

1 reference

8 December 2017

Krause G

4

1 reference

8 December 2017

O'Donovan DG

5

1 reference

8 December 2017

Horowitz M

6

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Alimentary Pharmacology & Therapeutics

8 December 2017

1 reference

8 December 2017

20

1 reference

8 December 2017

3

1 reference

8 December 2017

333-338

1 reference

Diabetic gastropathy and prokinetics

8 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02066.X

Oral erythromycin and symptomatic relief of gastroparesis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02066.X

Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02066.X

Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02066.X

Hyperglycemia attenuates erythromycin-induced acceleration of liquid-phase gastric emptying of hypertonic liquids in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02066.X

Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02066.X

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02066.X

10.1111/J.1365-2036.2004.02066.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference